K2 Principal Fund, L.P. Biote Corp. Transaction History
K2 Principal Fund, L.P.
- $307 Million
- Q4 2024
A detailed history of K2 Principal Fund, L.P. transactions in Biote Corp. stock. As of the latest transaction made, K2 Principal Fund, L.P. holds 49,651 shares of BTMD stock, worth $168,316. This represents 0.1% of its overall portfolio holdings.
Number of Shares
49,651
Previous 49,651
-0.0%
Holding current value
$168,316
Previous $277,000
11.91%
% of portfolio
0.1%
Previous 0.13%
Shares
1 transactions
Others Institutions Holding BTMD
# of Institutions
91Shares Held
18.6MCall Options Held
0Put Options Held
0-
325 Capital LLC New York, NY4.55MShares$15.4 Million12.7% of portfolio
-
Bandera Partners LLC New York, NY2.44MShares$8.26 Million5.9% of portfolio
-
Black Rock Inc. New York, NY1.61MShares$5.44 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.43MShares$4.85 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT1.35MShares$4.58 Million0.04% of portfolio
About biote Corp.
- Ticker BTMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Care Facilities
- Shares Outstandng 7,574,270
- Market Cap $25.7M
- Description
- biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biot...